Physician profile
Steven L Myerthall
NPI 1487691739
$690,811.86
in general payments reported to CMS, 2019-2025
8 companies · $100K in 2025
The $100K reported for 2025 was more than what 92% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230K · 2020: $44K · 2021: $110K · 2022: $49K · 2023: $68K · 2024: $90K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $213K · Travel and Lodging: $39K · Food and Beverage: $6,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $212,500.00 |
| Travel and Lodging | $38,890.97 |
| Food and Beverage | $6,168.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $689,623.60 | 2019-2025 | Mako, Triathlon, Aequalis |
| Smith+Nephew, INC. | $820.96 | 2021-2025 | Real Intelligence, Journey II, Legion Revision |
| Davol INC. | $135.41 | 2025 | Channel Drain |
| Amgen INC. | $125.00 | 2024 | Krystexxa |
| Biocomposites INC | $74.08 | 2025 | Stimulan |
| Globus Medical, INC. | $17.22 | 2024 | Distal Femur Plate System |
| Goode Surgical INC | $15.59 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Myerthall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.